Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,889
archived clinical trials in
Blood Cancer

Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Children's Memorial Hospital
mi
from
Chicago, IL
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Children's Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Advocate Hope Children's Hospital
mi
from
Oak Lawn, IL
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Advocate Hope Children's Hospital
mi
from
Oak Lawn, IL
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Indiana University Medical Center
mi
from
Indianapolis, IN
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Indiana University Medical Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Kosair Children's Hospital
mi
from
Louisville, KY
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Kosair Children's Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Dana-Farber Cancer Institute
mi
from
Boston, MA
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
C S Mott Children's Hospital
mi
from
Ann Arbor, MI
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
C S Mott Children's Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Washington University School of Medicine
mi
from
Saint Louis, MO
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Columbia University Medical Center
mi
from
New York, NY
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Mission Hospital
mi
from
Asheville, NC
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Mission Hospital
mi
from
Asheville, NC
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Rainbow Babies and Children's Hospital
mi
from
Cleveland, OH
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Rainbow Babies and Children's Hospital
mi
from
Cleveland, OH
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Oregon Health and Science University
mi
from
Portland, OR
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Rhode Island Hospital
mi
from
Providence, RI
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Medical University of South Carolina
mi
from
Charleston, SC
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
East Tennessee Children's Hospital
mi
from
Knoxville, TN
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
East Tennessee Children's Hospital
mi
from
Knoxville, TN
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Driscoll Children's Hospital
mi
from
Corpus Christi, TX
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Driscoll Children's Hospital
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Baylor College of Medicine
mi
from
Houston, TX
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Methodist Children's Hospital of South Texas
mi
from
San Antonio, TX
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Methodist Children's Hospital of South Texas
mi
from
San Antonio, TX
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Seattle Children's Hospital
mi
from
Seattle, WA
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Midwest Children's Cancer Center
mi
from
Milwaukee, WI
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Midwest Children's Cancer Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Princess Margaret Hospital for Children
mi
from
Perth,
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Princess Margaret Hospital for Children
mi
from
Perth,
Click here to add this to my saved trials
Motor Proficiency And Physical Activity in Adult Survivors of Childhood Acute Lymphoblastic Leukemia (ALL)
Motor Proficiency And Physical Activity in Adult Survivors of Childhood ALL
Status: Enrolling
Updated:  8/26/2015
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Motor Proficiency And Physical Activity in Adult Survivors of Childhood Acute Lymphoblastic Leukemia (ALL)
Motor Proficiency And Physical Activity in Adult Survivors of Childhood ALL
Status: Enrolling
Updated: 8/26/2015
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Concurrent School Attendance And Cancer Therapy: The Experiences of 6-12 Year Old Pediatric Oncology Patients
Concurrent School Attendance And Cancer Therapy: The Experiences of 6-12 Year Old Pediatric Oncology Patients
Status: Enrolling
Updated:  8/26/2015
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Concurrent School Attendance And Cancer Therapy: The Experiences of 6-12 Year Old Pediatric Oncology Patients
Concurrent School Attendance And Cancer Therapy: The Experiences of 6-12 Year Old Pediatric Oncology Patients
Status: Enrolling
Updated: 8/26/2015
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED)
A Phase I, Sequential Cohort, Dose Escalation Trial to Determine the Safety, Tolerability, and Maximum Tolerated Dose of Daily x 5 Administration of AP23573, an mTOR Inhibitor, in Patients With Refractory or Advanced Malignancies
Status: Enrolling
Updated:  8/26/2015
Cancer Therapy and Research Center, University of Texas Health Center at San Antonio
mi
from
San Antonio, TX
Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED)
A Phase I, Sequential Cohort, Dose Escalation Trial to Determine the Safety, Tolerability, and Maximum Tolerated Dose of Daily x 5 Administration of AP23573, an mTOR Inhibitor, in Patients With Refractory or Advanced Malignancies
Status: Enrolling
Updated: 8/26/2015
Cancer Therapy and Research Center, University of Texas Health Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Bupropion in Helping Adults Stop Smoking
A Phase II Study of the Effects of Extended Pre-Cessation Bupropion for Smoking Cessation
Status: Enrolling
Updated:  8/27/2015
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Bupropion in Helping Adults Stop Smoking
A Phase II Study of the Effects of Extended Pre-Cessation Bupropion for Smoking Cessation
Status: Enrolling
Updated: 8/27/2015
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer
Allogeneic Hematopoietic Stem Cell Transplantation for Induction of Mixed Hematopoietic Chimerism in Patients Infected With Human Immunodeficiency Virus-1 Using a Non-Marrow Ablative Conditioning Regimen Containing Total Body Irradiation in Combination With Post-Transplant Immunosuppression With Cyclosporine and Mycophenolate Mofetil
Status: Enrolling
Updated:  8/28/2015
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
mi
from
Seattle, WA
Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer
Allogeneic Hematopoietic Stem Cell Transplantation for Induction of Mixed Hematopoietic Chimerism in Patients Infected With Human Immunodeficiency Virus-1 Using a Non-Marrow Ablative Conditioning Regimen Containing Total Body Irradiation in Combination With Post-Transplant Immunosuppression With Cyclosporine and Mycophenolate Mofetil
Status: Enrolling
Updated: 8/28/2015
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
mi
from
Seattle, WA
Click here to add this to my saved trials
A Phase I Trial of Alloreactive Cell Infusion Following Transplantation of Haplotype Cells in Patients With Myeloid Malignancies
A PHASE I TRIAL OF ALLOREACTIVE NK CELLS INFUSION FOLLOWING TRANSPLANTATION OF HAPLOTYPE MISMATCHED, KIR MISMATCHED HIGHLY PURIFIED CD34 CELLS IN PATIENTS WITH ADVANCED OR REFRACTORY MYELOID MALIGNANCIES
Status: Enrolling
Updated:  8/28/2015
Indiana University Cancer Center
mi
from
Indianapolis, IN
A Phase I Trial of Alloreactive Cell Infusion Following Transplantation of Haplotype Cells in Patients With Myeloid Malignancies
A PHASE I TRIAL OF ALLOREACTIVE NK CELLS INFUSION FOLLOWING TRANSPLANTATION OF HAPLOTYPE MISMATCHED, KIR MISMATCHED HIGHLY PURIFIED CD34 CELLS IN PATIENTS WITH ADVANCED OR REFRACTORY MYELOID MALIGNANCIES
Status: Enrolling
Updated: 8/28/2015
Indiana University Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment
A Phase I Study of Compound 506U78 (NSC #686673) in Patients With Hematologic Malignancies and Renal or Hepatic Impairment
Status: Enrolling
Updated:  8/28/2015
University of Chicago Cancer Research Center
mi
from
Chicago, IL
506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment
A Phase I Study of Compound 506U78 (NSC #686673) in Patients With Hematologic Malignancies and Renal or Hepatic Impairment
Status: Enrolling
Updated: 8/28/2015
University of Chicago Cancer Research Center
mi
from
Chicago, IL
Click here to add this to my saved trials
506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment
A Phase I Study of Compound 506U78 (NSC #686673) in Patients With Hematologic Malignancies and Renal or Hepatic Impairment
Status: Enrolling
Updated:  8/28/2015
Holden Comprehensive Cancer Center at University of Iowa
mi
from
Iowa City, IA
506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment
A Phase I Study of Compound 506U78 (NSC #686673) in Patients With Hematologic Malignancies and Renal or Hepatic Impairment
Status: Enrolling
Updated: 8/28/2015
Holden Comprehensive Cancer Center at University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment
A Phase I Study of Compound 506U78 (NSC #686673) in Patients With Hematologic Malignancies and Renal or Hepatic Impairment
Status: Enrolling
Updated:  8/28/2015
Comprehensive Cancer Center of Wake Forest University
mi
from
Winston-Salem, NC
506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment
A Phase I Study of Compound 506U78 (NSC #686673) in Patients With Hematologic Malignancies and Renal or Hepatic Impairment
Status: Enrolling
Updated: 8/28/2015
Comprehensive Cancer Center of Wake Forest University
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Bortezomib and Vorinostat in Treating Patients With Multiple Myeloma Who Have Undergone Autologous Stem Cell Transplant
Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant for Multiple Myeloma
Status: Enrolling
Updated:  8/31/2015
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
mi
from
Seattle, WA
Bortezomib and Vorinostat in Treating Patients With Multiple Myeloma Who Have Undergone Autologous Stem Cell Transplant
Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant for Multiple Myeloma
Status: Enrolling
Updated: 8/31/2015
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
mi
from
Seattle, WA
Click here to add this to my saved trials
Lenalidomide in Comb w/Rituximab for Pts w/CD5+/CD20+ Hem Malignancies Who Relapse/Progress After Rituximab
A Phase II Study of Lenalidomide (REVLIMID®) in Combination With Rituximab for Patients With CD5+/CD20+ Hematologic Malignancies Who Relapse or Progress After Rituximab
Status: Enrolling
Updated:  9/1/2015
Center for Cancer Care & Research/Watson
mi
from
Lakeland, FL
Lenalidomide in Comb w/Rituximab for Pts w/CD5+/CD20+ Hem Malignancies Who Relapse/Progress After Rituximab
A Phase II Study of Lenalidomide (REVLIMID®) in Combination With Rituximab for Patients With CD5+/CD20+ Hematologic Malignancies Who Relapse or Progress After Rituximab
Status: Enrolling
Updated: 9/1/2015
Center for Cancer Care & Research/Watson
mi
from
Lakeland, FL
Click here to add this to my saved trials
Lenalidomide in Comb w/Rituximab for Pts w/CD5+/CD20+ Hem Malignancies Who Relapse/Progress After Rituximab
A Phase II Study of Lenalidomide (REVLIMID®) in Combination With Rituximab for Patients With CD5+/CD20+ Hematologic Malignancies Who Relapse or Progress After Rituximab
Status: Enrolling
Updated:  9/1/2015
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
Lenalidomide in Comb w/Rituximab for Pts w/CD5+/CD20+ Hem Malignancies Who Relapse/Progress After Rituximab
A Phase II Study of Lenalidomide (REVLIMID®) in Combination With Rituximab for Patients With CD5+/CD20+ Hematologic Malignancies Who Relapse or Progress After Rituximab
Status: Enrolling
Updated: 9/1/2015
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer
A Phase II Trial of Non-Myeloablative Conditioning and Transplantation of Partially HLA-Mismatched Bone Marrow for Patients With Hematologic Malignancies
Status: Enrolling
Updated:  9/2/2015
Blood and Marrow Transplant Program at Northside Hospital
mi
from
Atlanta, GA
Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer
A Phase II Trial of Non-Myeloablative Conditioning and Transplantation of Partially HLA-Mismatched Bone Marrow for Patients With Hematologic Malignancies
Status: Enrolling
Updated: 9/2/2015
Blood and Marrow Transplant Program at Northside Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer
A Phase II Trial of Non-Myeloablative Conditioning and Transplantation of Partially HLA-Mismatched Bone Marrow for Patients With Hematologic Malignancies
Status: Enrolling
Updated:  9/2/2015
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer
A Phase II Trial of Non-Myeloablative Conditioning and Transplantation of Partially HLA-Mismatched Bone Marrow for Patients With Hematologic Malignancies
Status: Enrolling
Updated: 9/2/2015
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer
A Phase II Trial of Non-Myeloablative Conditioning and Transplantation of Partially HLA-Mismatched Bone Marrow for Patients With Hematologic Malignancies
Status: Enrolling
Updated:  9/2/2015
Hahnemann University Hospital
mi
from
Philadelphia, PA
Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer
A Phase II Trial of Non-Myeloablative Conditioning and Transplantation of Partially HLA-Mismatched Bone Marrow for Patients With Hematologic Malignancies
Status: Enrolling
Updated: 9/2/2015
Hahnemann University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Expanded Access Single Named Patient Program With Elotuzumab (BMS-901608) for the Treatment of Patient R-A With Relapsed/Refractory Multiple Myeloma
Expanded Access Single Named Patient Program With Elotuzumab (BMS-901608) for the Treatment of Patient R-A With Relapsed/Refractory Multiple Myeloma
Status: Enrolling
Updated:  9/2/2015
Icahn School.of Medicine at Mount Sinai
mi
from
New York, NY
Expanded Access Single Named Patient Program With Elotuzumab (BMS-901608) for the Treatment of Patient R-A With Relapsed/Refractory Multiple Myeloma
Expanded Access Single Named Patient Program With Elotuzumab (BMS-901608) for the Treatment of Patient R-A With Relapsed/Refractory Multiple Myeloma
Status: Enrolling
Updated: 9/2/2015
Icahn School.of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Phase I/II Study of hLL1-DOX in Relapsed NHL and CLL
A Phase I/II Study of Immunotherapy With hLL1-DOX in Patients With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
Status: Enrolling
Updated:  9/3/2015
Helen F. Graham Cancer Center
mi
from
Newark, DE
Phase I/II Study of hLL1-DOX in Relapsed NHL and CLL
A Phase I/II Study of Immunotherapy With hLL1-DOX in Patients With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
Status: Enrolling
Updated: 9/3/2015
Helen F. Graham Cancer Center
mi
from
Newark, DE
Click here to add this to my saved trials
Phase I/II Study of hLL1-DOX in Relapsed NHL and CLL
A Phase I/II Study of Immunotherapy With hLL1-DOX in Patients With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
Status: Enrolling
Updated:  9/3/2015
M.D. Anderson Cancer Center at Orlando
mi
from
Orlando, FL
Phase I/II Study of hLL1-DOX in Relapsed NHL and CLL
A Phase I/II Study of Immunotherapy With hLL1-DOX in Patients With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
Status: Enrolling
Updated: 9/3/2015
M.D. Anderson Cancer Center at Orlando
mi
from
Orlando, FL
Click here to add this to my saved trials
Phase I/II Study of hLL1-DOX in Relapsed NHL and CLL
A Phase I/II Study of Immunotherapy With hLL1-DOX in Patients With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
Status: Enrolling
Updated:  9/3/2015
Iu Health Goshen Center For Cancer Care
mi
from
Goshen, IN
Phase I/II Study of hLL1-DOX in Relapsed NHL and CLL
A Phase I/II Study of Immunotherapy With hLL1-DOX in Patients With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
Status: Enrolling
Updated: 9/3/2015
Iu Health Goshen Center For Cancer Care
mi
from
Goshen, IN
Click here to add this to my saved trials
Phase I/II Study of hLL1-DOX in Relapsed NHL and CLL
A Phase I/II Study of Immunotherapy With hLL1-DOX in Patients With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
Status: Enrolling
Updated:  9/3/2015
John Theurer Cancer Center at the Hackensack University Medical Center
mi
from
Hackensack, NJ
Phase I/II Study of hLL1-DOX in Relapsed NHL and CLL
A Phase I/II Study of Immunotherapy With hLL1-DOX in Patients With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
Status: Enrolling
Updated: 9/3/2015
John Theurer Cancer Center at the Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Phase I/II Study of hLL1-DOX in Relapsed NHL and CLL
A Phase I/II Study of Immunotherapy With hLL1-DOX in Patients With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
Status: Enrolling
Updated:  9/3/2015
U.T. MD Anderson Cancer Center Houston
mi
from
Houston, TX
Phase I/II Study of hLL1-DOX in Relapsed NHL and CLL
A Phase I/II Study of Immunotherapy With hLL1-DOX in Patients With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
Status: Enrolling
Updated: 9/3/2015
U.T. MD Anderson Cancer Center Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Phase I/II Study of hLL1-DOX in Relapsed NHL and CLL
A Phase I/II Study of Immunotherapy With hLL1-DOX in Patients With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
Status: Enrolling
Updated:  9/3/2015
UMass Memorial Cancer Center of Excellence
mi
from
Worcester, MA
Phase I/II Study of hLL1-DOX in Relapsed NHL and CLL
A Phase I/II Study of Immunotherapy With hLL1-DOX in Patients With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
Status: Enrolling
Updated: 9/3/2015
UMass Memorial Cancer Center of Excellence
mi
from
Worcester, MA
Click here to add this to my saved trials
A Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone in Previously Untreated Subjects With Multiple Myeloma
A Multicenter, Randomized, Parallel-group , Double Blind, Placebo-controlled Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone as Induction Therapy for Previously Untreated Subjects With Multiple Myeloma
Status: Enrolling
Updated:  9/9/2015
Clinical Research Consultants, Inc.
mi
from
Hoover, AL
A Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone in Previously Untreated Subjects With Multiple Myeloma
A Multicenter, Randomized, Parallel-group , Double Blind, Placebo-controlled Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone as Induction Therapy for Previously Untreated Subjects With Multiple Myeloma
Status: Enrolling
Updated: 9/9/2015
Clinical Research Consultants, Inc.
mi
from
Hoover, AL
Click here to add this to my saved trials
A Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone in Previously Untreated Subjects With Multiple Myeloma
A Multicenter, Randomized, Parallel-group , Double Blind, Placebo-controlled Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone as Induction Therapy for Previously Untreated Subjects With Multiple Myeloma
Status: Enrolling
Updated:  9/9/2015
Arizona Clinical Research Center
mi
from
Tucson, AZ
A Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone in Previously Untreated Subjects With Multiple Myeloma
A Multicenter, Randomized, Parallel-group , Double Blind, Placebo-controlled Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone as Induction Therapy for Previously Untreated Subjects With Multiple Myeloma
Status: Enrolling
Updated: 9/9/2015
Arizona Clinical Research Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone in Previously Untreated Subjects With Multiple Myeloma
A Multicenter, Randomized, Parallel-group , Double Blind, Placebo-controlled Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone as Induction Therapy for Previously Untreated Subjects With Multiple Myeloma
Status: Enrolling
Updated:  9/9/2015
UCLA School of Medicine
mi
from
Los Angeles, CA
A Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone in Previously Untreated Subjects With Multiple Myeloma
A Multicenter, Randomized, Parallel-group , Double Blind, Placebo-controlled Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone as Induction Therapy for Previously Untreated Subjects With Multiple Myeloma
Status: Enrolling
Updated: 9/9/2015
UCLA School of Medicine
mi
from
Los Angeles, CA
Click here to add this to my saved trials